skip to Main Content
LIVER CANCER SUMMIT 2020

06-08 February

Prague, Czech Republic

The latest research and findings on liver cancer are now online.

Download the abstracts
Abstract submission opens 06/08/2019
Abstract submission deadline 26/11/2019
Notification 18/12/2019
Bursary notification 18/12/2019
Abstracts online 23/01/2020

All accepted abstracts submitted in this format (abstract /late-breaker abstract) must be either presented as:

  1. An oral presentation

OR

  1. A ePoster presentation (which upon selection can also be included as an oral ePoster sessions)

Free of charge for this event.

Download the template.

To submit this template you can log in to the abstract submission platform.

  • All changes can be made by the abstract submitter until the abstract submission deadline
  • Therefore, after the abstract submission deadline only the presenting author can be changed until 3 weeks prior the event
  • After acceptance of the abstract, requests for withdrawal of an abstract must be received in writing to abstracts@easloffice.eu by the abstract submission deadline: 26 November 2019
  • Therefore, any withdrawal requested after that date will not be considered and the abstract will be published
  • Conflict of interest: For each author, any relevant financial relationship with the provider of commercial products or services discussed in their educational presentation or that are directly supporting the CME activity through an educational grant to the sponsoring organization(s)
  • Off label products: If the product, that is discussed in the abstract, is not labelled for the use under discussion or that the product is still investigational

Note: The intent of disclosure is not to prevent a participant with financial or other relationships from making a presentation, but rather to provide participants with adequate information about the relationship(s).

All abstracts will be available publicly on the conference website 2 weeks prior to the event.

Therefore the information contained in the abstracts accepted for this event will be under embargo until two weeks prior to the event.

Finally, abstracts will be available under the abstract menu tab of this website.

Please refer to the scientific programme timetable for exact details.

Violation of this policy will be taken seriously. Individuals and/or sponsors who violate it may face sanctions relating to current and future abstract submissions, presentations and visibility at any EASL event. The EASL Governing Board is at liberty to ban attendance and/or retract data.

By submitting an abstract to an EASL event you agree with the following statement:

“I hereby assign all copyrights to the European Association for the Study of the Liver (EASL), for the abstract submitted to the EASL monothematic conference on: “Translational research in viral hepatitis: Addressing the gaps for cure” (government authors not electing to transfer, agree to assign an exclusive publishing and distribution license) and any supplemental tables, illustrations or other information submitted therewith that are intended for publication as part of the abstract in all forms and media (whether now known or hereafter developed), throughout the world, in all languages, for the full term of copyright, effective when, and if, the article is accepted for publication. This transfer includes the right to provide the abstract in electronic and online forms and systems.”

Author copyright

Copyrights related to abstract data made available on the website and in the printed material resides with the respective authors. Therefor no reproduction, re-use or transcription for any commercial purpose or use of the content is permitted without the written permission of the authors. Most importantly permission for re-use must be obtained directly from the author.

Violation of this policy will be taken seriously. Individuals and/or sponsors who violate it may face sanctions relating to current and future abstract submissions, presentations and visibility at any EASL event. The EASL Governing Board is at liberty to ban attendance and/or retract data.

Still have question? Feel free to contact us here